← SynDRA
VILANTEROL
SynDRA canonical compound SYN0022906 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
| Indication | chronic obstructive pulmonary disease (COPD) |
|---|
| Disease area | pulmonary |
|---|
All known targets
Mechanisms of action (all sources)
- ADRB2 AGONIST
- Beta-2 adrenergic receptor agonist
- adrenergic receptor agonist
- ADRB2 MODULATOR
Drug classes
- Adrenergic beta2-Agonists
- beta2-Adrenergic Agonist
ATC classes
Cross-references
Synonyms
- GW642444X
- Breo Ellipta
- vilanterol trifenatate
- GW642444M
- GW-642444
- GW-642444X
- GW642444
- Fumagillinum
- Fumagilline
- Fumagilina
- Fumidil
- Fugillin
- UNII-7OW73204U1
- Amebacillin
- Fugilin
- CHEMBL32838
- Fumagillin DCH
- CHEBI:48635
- Fumagillina [DCIT]
- 7OW73204U1
- Fumagillinum [INN-Latin]
- Fumagilline [INN-French]
- Fumagilina [INN-Spanish]
- DSSTox_RID_79580
- DSSTox_CID_20736
- DSSTox_GSID_40736
- Fumagillin [INN:BAN:DCF]
- 2,4,6,8-Decatetraenedioic acid, 4-(1,2-epoxy-1,5-dimethyl-4-hexenyl)-5-methoxy-1-oxaspiro(2,5)oct-6-yl ester
- GW642444x
- UNII-028LZY775B
- GW-642444x
- CHEBI:75037
- 028LZY775B
- Vilanterol (GW642444
- GW 642444X)
- 4-((1R)-2-((6-(2-((2,6-dichlorophenyl)methoxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol
- 4-[(1R)-2-[(6-{2-[(2,6-dichlorophenyl)methoxy]ethoxy}hexyl)amino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol
- Vilanterol [USAN:INN]
Look up VILANTEROL in the interactive SynDRA portal →